Georgia Institute of Technology
Development and Evaluation of Rapid Antimicrobial Susceptibility Testing Technologies for Bloodstream Infections
Abstract
dc:description.abstractBloodstream infections (BSIs) have become increasingly challenging to treat due to emerging antimicrobial resistance (AMR), hence, phenotypic antimicrobial susceptibility testing (AST) remains the gold standard. As rapid administration of appropriate antimicrobial is crucial for patient survival during BSIs, alternatives to lengthy gold standard phenotypic method must be developed. Delayed AST results not only decrease patient survival probability but also contribute to AMR proliferation. The low bacterial loads ≤10 CFU/mL leading to BSI mandates blood culture to amplify bacterial numbers for testing. Blood cultures can take ~24 hours to 7 days to flag positive. Although multiple efforts have been made to hasten ASTs after blood culture positivity, most of the currently implemented commercial instrumentation in clinical practices still have long turn around times (TAT), requiring isolation of pure colonies post blood culture positivity. Despite being automated, the requirement of pure colonies delay the ASTs requiring ~30 hours or more to get susceptibility results after blood culture positivity. Every hour is crucial when it comes to sepsis, a condition largely caused by BSIs, as each hour delay further increased the mortality by ~7.6% after onset of symptoms. This thesis focuses on developing rapid, cost effective, low labor, automated, and accurate AST systems for BSIs/sepsis. To achieve this, an automated colorimetric technique (ChroMIC) that yields real-time minimum inhibitory concentrations (MICs) over the course of the assay is developed. The initial study performed using seven antibiotics showed no false susceptibilities and high accuracies with respect to standard broth microdilution (BMD). Moreover, a retrospective study suggests implementation of ChroMIC would have facilitated rapid escalation and de-escalation of antimicrobial therapy within 7 hours where the clinical median timelines were 43.8 hours and 52.6 hours respectively post PBCs. Also, a label-free rapid spectroscopic AST that gives susceptibility results 18 h post PBCs was developed. To overcome the limitations of conventional plate readers, cost-effective custom-built printed circuit boards (PCBs) were developed and evaluated for rapid label-free automated real-time AST directly from PBCs. All these developed technologies were tested using adult and pediatric clinical BSI samples within 8 hours of being flagged positive. The accuracy and errors of these assays were evaluated against gold standard BMD. Furthermore, to push the AST timeline, a novel ultra-fast pre-blood culture AST was developed. This ultra-fast AST can be performed both colorimetrically as well as spectroscopically. This pre-blood culture assays can provide phenotypic susceptibility results within ~12 hours as opposed to the days required by the existing phenotypic technologies.
Degree
thesis:*- Level thesis:degree_level
- Doctoral
- Department dc:contributor.department
- Chemistry and Biochemistry
- Grantor dc:publisher
- Georgia Institute of Technology
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Khanal, Prakash Chandra
- Advisor dc:contributor.advisor
-
- Dickson, Robert M.
- Committee members dc:contributor.committeemember
-
- Fernandez, Facundo
- Stockton, Amanda
- Cicerone, Marcus
- Brown, Sam
- Tzeng, Yih-Ling
Subjects
dc:subject × 8Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/1853/82028